Condition Focus: Osteoarthritis — Meta-Analytic Confirmation of Biomarker Effects
The question of whether photobiomodulation reliably reduces inflammatory biomarkers — or whether positive findings are scattered and inconsistent — is directly addressed by this 2021 systematic review from Nambi in Lasers in Medical Science. By pooling results across multiple rat OA studies using different induction methods, the review tested whether LLLT’s effects on key biomarkers are reproducible.
The answer was clear: IL-1β, TNF-α, and MMP-13 were consistently reduced across studies, regardless of the specific OA induction method used. This consistency is important because it suggests the anti-inflammatory effects are not model-dependent — they reflect a genuine biological response to PBM rather than an artifact of a particular experimental setup.
The inclusion of MMP-13 (matrix metalloproteinase-13) adds a dimension that many inflammation-focused reviews miss. MMP-13 is the primary enzyme responsible for degrading type II collagen — the structural protein that gives cartilage its load-bearing capacity. In gout, MMP-13 is upregulated during flares and contributes to the progressive cartilage erosion seen in chronic tophaceous disease. The finding that PBM consistently suppresses MMP-13 suggests a cartilage-protective effect that extends beyond simple anti-inflammatory activity.
G.O.A.T. for Gout Alignment:
The G.O.A.T.’s parameters fall within the LLLT ranges reviewed in this analysis. The consistent biomarker suppression confirmed here — particularly the MMP-13 finding — supports the G.O.A.T.’s positioning for both acute flare management (IL-1β, TNF-α suppression) and long-term joint protection (MMP-13 suppression, cartilage preservation).
Link to original research here
Editor’s note: The individual study-level data behind this meta-analysis is exemplified by Tomazoni et al 2017, which measured all four key mediators in a single experiment. The cartilage-protective implications of MMP-13 suppression connect to the cartilage matrix synthesis evidence in Oliveira et al 2025 and the proteoglycan restoration data in Balbinot et al 2021. For the neutrophil-driven joint inflammation that these biomarkers mediate, see Alves et al 2014.
Related Articles
- Effects of PBM on Inflammatory Response in Experimental OA – Tomazoni et al 2017
- NIR PBM Stimulates Cartilage Matrix Synthesis in Human Chondrocytes – Oliveira et al 2025
- PBM Restores Cartilage Integrity and Reduces Chronic Pain in OA – Balbinot et al 2021
- Effect of PBM on Inflammatory Mediators and Neutrophils in Joint Inflammation – Alves et al 2014
- Effects of PBM on OA from In Vivo and In Vitro Studies – Narrative Review 2025
Key Takeaways
- Meta-analysis confirms consistent IL-1β, TNF-α, and MMP-13 reduction with LLLT across OA models
- Consistency across different OA induction methods — effects are not model-dependent
- MMP-13 suppression indicates cartilage-protective effects beyond anti-inflammatory activity
- MMP-13 is the primary collagen-degrading enzyme, also upregulated in chronic gout
Study Overview
| Study Type: | Systematic review (meta-analysis of preclinical studies) |
| Wavelength(s): | Multiple LLLT parameters across included studies |
| Treatment Protocol: | Varies across included studies |
| Sample Size: | Multiple rat OA studies pooled (various induction methods) |
| Primary Outcome: | Consistent reduction of IL-1β, TNF-α, and MMP-13 across studies |
Full Citation
Nambi G. (2021). Does low-level laser therapy have effects on inflammatory biomarkers of IL-1β, IL-6, TNF-α, and MMP-13 in osteoarthritis of rat models? A systematic review. Lasers in Medical Science, 36(3), 475–484. View Publication
